Terms and Conditions for Grant Applications
- Rationale. The trial or study must address a legitimate medical or scientific question affecting the use of a Bristol-Myers Squibb drug and not duplicate other planned or conducted research unless justified on a scientific or medical basis.
- Sponsor. The applicant (investigator, cooperative group, institution, network) must be qualified and capable of conducting the proposed study in compliance with International Conference on Harmonization's Good Clinical Practices, U.S. Food & Drug Administrations Good Clinical Practices, European Medicines Agency Good Clinical Practice. The sponsor must comply with all applicable legal and regulatory requirements and must not be the subject of any legal or regulatory restrictions or sanctions.
- Medical appropriateness of proposed research. The proposed research must be reasonably likely to produce results that could beneficially impact medical therapy for the condition being investigated.
- Scientific validity. The proposed study procedures must fulfill the stated objectives of the study.
- Ethical considerations. The study must be designed to meet ethical guidelines concerning human subjects in research (for interventional research) according to the Declaration of Helsinki.
- Financial support. Funding requests must reasonably reflect the cost and effort involved and should not be used to defray normal operating expenses of the sponsor-investigator or institution that are not directly related to the supported research. An executed research agreement must be in place prior to any study commencing.
- All applicable regulatory requirements, including but not limited to study registration and results disclosure, must be observed.
- Publication of research results. The results of the research will be collected and analyzed and a report of the study will be prepared and planned for potential publication in a peer-reviewed journal.
- Priority. We consider requests for clinical research trials in all clinical and therapeutic areas, and give priority to proposals in the cardiovascular/metabolics, neuroscience, cancer, immunology and virology therapeutic areas.
All support for investigator-sponsored research is awarded at the sole discretion of Bristol-Myers Squibb based on the criteria set forth above, and is subject to the terms of a grant agreement signed by the parties.
- Acceptance of Terms and Conditions. Your submission of a clinical research grant application indicates your agreement to, and is subject to the above terms and conditions and all applicable laws.
- Governing Law. This agreement and its performance shall be governed by the laws of the state of New Jersey, United States of America, without regard to its conflict of laws provisions. You consent and submit to the exclusive jurisdiction of the state and federal courts located in Mercer County, the state of New Jersey, United States of America, in all questions and controversies arising out of your submission of a grant application. To the extent allowed by applicable law, any claim or cause of action arising from or relating to your submission of a grant application must be brought within two (2) years from the date on which such claim or action arose or accrued.
For Australian Investigators
Privacy
BMS respects your privacy, and complies with the Privacy Act 1988 (Cth) and the National Privacy Principles. For further details on how BMS collects, stores, uses and discloses your personal information please see our privacy statement at www.bmsa.com.au. If you wish to enquire about any personal information that BMS holds about you, cease receiving information from us, or request a copy of the BMS privacy statement then please write to us c/o The Privacy Officer, Bristol-Myers Squibb Australia Pty Ltd, 556 Princes Hwy, Noble Park North, VIC, 3174.
Privacy Disclaimer
The information requested and filled in the submission form below will be used and processed in the US by Bristol-Myers Squib Company (BMS) in order to review and manage your IST/ISS submission. The information will be treated confidentially and only accessed by authorized BMS and their affiliates (including agents, contractors or consultants). Individuals have a right of access to and verification of their personal information collected and maintained within the IST/ISS online submission as well as a right to object to the processing of their personal data, by clicking here. Nevertheless, in case of objection, individuals may not be able to participate in the particular activity that requires the information. All personnel whose personal data are filled in this submission form must be in agreement with the above privacy disclaimer. Therefore, before filling in information on another person, you must have collected her or his individual permission while cascading the above privacy disclaimer.